Lumigan (Bimatoprost) - Indications and Dosage

INDICATIONS AND USAGE

LUMIGAN ^® (bimatoprost ophthalmic solution) 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

DOSAGE AND ADMINISTRATION

The recommended dosage is one drop in the affected eye(s) once daily in the evening. The dosage of LUMIGAN ^® (bimatoprost ophthalmic solution) 0.03% should not exceed once daily since it has been shown that more frequent administration may decrease the intraocular pressure lowering effect.

Reduction of the intraocular pressure starts approximately 4 hours after the first administration with maximum effect reached within approximately 8 to 12 hours.

LUMIGAN ^® may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.

HOW SUPPLIED

LUMIGAN ^® (bimatoprost ophthalmic solution) 0.03% is supplied sterile in opaque white low density polyethylene ophthalmic dispenser bottles and tips with turquoise polystyrene caps in the following sizes:

•  2.5 mL fill in 5 mL container – NDC 0023-9187-03
•  5 mL fill in 10 mL container – NDC 0023-9187-05
•  7.5 mL fill in 10 mL container – NDC 0023-9187-07

Storage: LUMIGAN ^® should be stored in the original container at 2°to 25°C (36° to 77°F).

Rx only

Revised September 2006

© 2006 Allergan, Inc.
Irvine, CA 92612

^® marks owned by Allergan, Inc.

US Patents 5,688,819 and 6,403,649.
9106X
71669US11T